Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhlis Cem Ar

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Current Opinion in Rheumatology|November 10, 2025
Vasculitis associated with haematologic malignanciesAyse Salihoglu, Muhlis Cem Ar
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|May 16, 2019
Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia PatientsMuhlis Cem Ar, Can Balkan, Kaan Kavaklı
Expert Review of Hematology|November 5, 2016
Personalized prophylaxis in people with hemophilia A: challenges and achievementsMuhlis Cem Ar, Zafer Baslar, Teoman Soysal
Expert Review of Hematology|September 29, 2015
Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomideAyse Salihoglu, Muhlis Cem Ar, Teoman Soysal
Leukemia & Lymphoma|August 6, 2014
The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?Ahmet Emre Eskazan, Muhlis Cem Ar, Teoman Soysal
Expert Review of Hematology|September 9, 2016
Critical appraisal of European LeukemiaNet (ELN) 2013 recommendations for the management of chronic myeloid leukemia: is it early for a warning?Ahmet Emre Eskazan, Muhlis Cem Ar, Teoman Soysal
Transfusion|January 7, 2012
Intracranial extramedullary hematopoiesis in patients with thalassemia: a case report and review of the literatureAhmet Emre Eskazan, Muhlis Cem Ar, Zafer Baslar
British Journal of Haematology|December 24, 2010
Intracranial mass in a patient with thalassaemia majorAhmet Emre Eskazan, Muhlis Cem Ar, Zafer Baslar
Expert Review of Hematology|October 9, 2014
Generics in chronic myeloid leukemia: current arguments for and against and the established evidenceTeoman Soysal, Ahmet Emre Eskazan, Muhlis Cem Ar
Expert Review of Hematology|June 10, 2017
Comment and response to: the significance of early warning in chronic myeloid leukemiaAhmet Emre Eskazan, Muhlis Cem Ar, Teoman Soysal
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Current Opinion in Rheumatology|November 10, 2025
Vasculitis associated with haematologic malignanciesAyse Salihoglu, Muhlis Cem Ar
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|May 16, 2019
Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia PatientsMuhlis Cem Ar, Can Balkan, Kaan Kavaklı
Expert Review of Hematology|November 5, 2016
Personalized prophylaxis in people with hemophilia A: challenges and achievementsMuhlis Cem Ar, Zafer Baslar, Teoman Soysal
Expert Review of Hematology|September 29, 2015
Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomideAyse Salihoglu, Muhlis Cem Ar, Teoman Soysal
Leukemia & Lymphoma|August 6, 2014
The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?Ahmet Emre Eskazan, Muhlis Cem Ar, Teoman Soysal
Expert Review of Hematology|September 9, 2016
Critical appraisal of European LeukemiaNet (ELN) 2013 recommendations for the management of chronic myeloid leukemia: is it early for a warning?Ahmet Emre Eskazan, Muhlis Cem Ar, Teoman Soysal
Transfusion|January 7, 2012
Intracranial extramedullary hematopoiesis in patients with thalassemia: a case report and review of the literatureAhmet Emre Eskazan, Muhlis Cem Ar, Zafer Baslar
British Journal of Haematology|December 24, 2010
Intracranial mass in a patient with thalassaemia majorAhmet Emre Eskazan, Muhlis Cem Ar, Zafer Baslar
Expert Review of Hematology|October 9, 2014
Generics in chronic myeloid leukemia: current arguments for and against and the established evidenceTeoman Soysal, Ahmet Emre Eskazan, Muhlis Cem Ar
Expert Review of Hematology|June 10, 2017
Comment and response to: the significance of early warning in chronic myeloid leukemiaAhmet Emre Eskazan, Muhlis Cem Ar, Teoman Soysal
Pageof 11